
Commentary|Articles|February 27, 2026
Revised Childhood Immunization Schedule Lacks Transparency: Former ACIP Member Noel T. Brewer, PhD
Author(s)Brooke McCormick, Noel T. Brewer, PhD
Fact checked by: Maggie L. Shaw
Noel T. Brewer, PhD, former ACIP member, warns that the CDC's reduction from 17 to 11 recommended immunizations lacks transparency, which may lower uptake.
Advertisement
Advertisement
Early last month, the CDC
Related to this article

Non-US-born adults had higher CRC screening nonadherence than US-born adults, particularly those with less than 15 years of US residence.

The once weekly self-injected treatment is the first dual-binding nanobody C5 inhibitor approved for adults with AChR antibody-positive gMG.

Merck has begun the phase 3 ENHANCE-3 trial testing whether ensifentrine added to standard of care prevents COPD exacerbations in high-risk adults.

A new tool puts this year's measles toll at nearly $83 million as global health experts weigh whether the US has lost elimination status.

The FDA approved asundexian (Sunharbo) with antiplatelet therapy to reduce recurrent stroke risk after noncardioembolic stroke or high-risk TIA.

FDA approves dexmedetomidine sublingual film for at-home use in adults with schizophrenia, schizoaffective disorder, or bipolar I or II disorder.

A TriNetX retrospective cohort found adults with alopecia areata—especially women—face a nearly doubled glaucoma risk, with implications for ophthalmology and comorbidities.
Advertisement
Advertisement

